ADARx Pharmaceuticals Inc. IPO Research Information

ADARx Pharmaceuticals Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on ADARx Pharmaceuticals Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
ADARx Pharmaceuticals Inc.	ADRX - NASDAQ	$15.00-$17.00	$17.00	$22.10	26.25 million	9/25/2026
Underwriter(s): J.P. Morgan, Morgan Stanley, TD Cowen, UBS Investment Bank, LifeSci Capital
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2026-09-04 Terms Added 2026-09-21

ADARx Pharmaceuticals Inc. Quote & Chart - Click for current quote - ADRX

About ADARx Pharmaceuticals Inc. (adapted from ADARx Pharmaceuticals Inc. prospectus):
They are a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ADRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.